{
    "clinical_study": {
        "@rank": "114522", 
        "brief_summary": {
            "textblock": "The purpose of this study is to compare the safety and effectiveness of two anti-HIV drug\n      combinations when given to HIV-infected patients who have never been treated with anti-HIV\n      drugs. One drug combination is stavudine (d4T) plus didanosine (ddI) plus Crixivan. The\n      other combination is Retrovir (AZT) plus Epivir (3TC) plus Crixivan."
        }, 
        "brief_title": "A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients", 
        "condition": "HIV Infections", 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome"
            ]
        }, 
        "detailed_description": {
            "textblock": "100 patients will be randomized to receive Zerit (Stavudine) + Videx (Didanosine) + Crixivan\n      (Indinavir) and 100 patients will be randomized to receive Retrovir (Zidovudine) + Epivir\n      (Lamivudine) + Crixivan (Indinavir).\n\n      Patients will be treated for 48 weeks."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Patients must have:\n\n          -  Documented HIV infection.\n\n          -  CD4 cell count of 200 - 700 cells/mm3.\n\n        Exclusion Criteria\n\n        Co-existing Condition:\n\n        Patients with the following symptoms or conditions are excluded:\n\n        AIDS defining condition within 1 month of study entry.\n\n        Prior Medication:\n\n        Excluded:\n\n        Patients with any history of antiretroviral therapy treatment."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "16 Years"
        }, 
        "enrollment": "200", 
        "firstreceived_date": "November 2, 1999", 
        "id_info": {
            "nct_id": "NCT00002168", 
            "org_study_id": "260B", 
            "secondary_id": "BMS 002"
        }, 
        "intervention": [
            {
                "intervention_name": "Indinavir sulfate", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Lamivudine", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Stavudine", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Zidovudine", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Didanosine", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Didanosine", 
                "Zidovudine", 
                "Stavudine", 
                "Lamivudine", 
                "Reverse Transcriptase Inhibitors", 
                "Indinavir", 
                "HIV Protease Inhibitors"
            ]
        }, 
        "keyword": [
            "Didanosine", 
            "Drug Therapy, Combination", 
            "Zidovudine", 
            "Stavudine", 
            "HIV Protease Inhibitors", 
            "CD4 Lymphocyte Count", 
            "Lamivudine", 
            "Indinavir", 
            "Reverse Transcriptase Inhibitors", 
            "Anti-HIV Agents", 
            "Viral Load"
        ], 
        "lastchanged_date": "October 1, 2007", 
        "link": [
            {
                "description": "BMS Clinical Trials Disclosure", 
                "url": "http://ctr.bms.com/ctd/start.do"
            }, 
            {
                "description": "For FDA Safety Alerts and Recalls refer to the following link www.fda.gov/MEDWATCH/safety.htm", 
                "url": "http://www.fda.gov/MEDWATCH/safety.htm"
            }
        ], 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Berkeley", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94705"
                    }, 
                    "name": "East Bay AIDS Clinic"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Torrance", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90509"
                    }, 
                    "name": "Harbor UCLA Med Ctr / Division of Immunology / N-24"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20037"
                    }, 
                    "name": "George Washington Med Ctr / Clinical Trials Unit"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20037"
                    }, 
                    "name": "Anderson Clinical Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60611"
                    }, 
                    "name": "Northwestern Univ"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60610"
                    }, 
                    "name": "Chicago Ctr for Clinical Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Omaha", 
                        "country": "United States", 
                        "state": "Nebraska", 
                        "zip": "68195"
                    }, 
                    "name": "Univ of Nebraska"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chapel Hill", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27599"
                    }, 
                    "name": "Univ of North Carolina / Infectious Disease Division"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Charlotte", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "28207"
                    }, 
                    "name": "The Nalle Clinic / Clinical Research Dept"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19104"
                    }, 
                    "name": "Univ of Pennsylvania / Infectious Diseases Division"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75225"
                    }, 
                    "name": "Southwest Infectious Disease Association / PA"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75235"
                    }, 
                    "name": "Univ of Texas Southwestern Med Ctr of Dallas"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ponce", 
                        "country": "Puerto Rico", 
                        "zip": "00731"
                    }, 
                    "name": "Hosp Regional de Ponce - Area Vieja"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Puerto Rico"
            ]
        }, 
        "official_title": "An Open Label, Randomized, Comparative Study of Zerit (d4T) + Videx (ddI) + Crixivan Versus Retrovir (AZT) + Epivir (3TC) + Crixivan in HIV-Infected, Antiretroviral Naive Subjects With CD4 Cell Counts of 200 - 700/mm3 and HIV RNA Baseline Copy Number of >= 10,000 Copies/ml", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002168"
        }, 
        "source": "Bristol-Myers Squibb", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Bristol-Myers Squibb", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2007"
    }, 
    "geocoordinates": {
        "Anderson Clinical Research": "38.895 -77.036", 
        "Chicago Ctr for Clinical Research": "41.878 -87.63", 
        "East Bay AIDS Clinic": "37.872 -122.273", 
        "George Washington Med Ctr / Clinical Trials Unit": "38.895 -77.036", 
        "Harbor UCLA Med Ctr / Division of Immunology / N-24": "33.836 -118.341", 
        "Hosp Regional de Ponce - Area Vieja": "18.011 -66.614", 
        "Northwestern Univ": "41.878 -87.63", 
        "Southwest Infectious Disease Association / PA": "32.803 -96.77", 
        "The Nalle Clinic / Clinical Research Dept": "35.227 -80.843", 
        "Univ of Nebraska": "41.252 -95.998", 
        "Univ of North Carolina / Infectious Disease Division": "35.913 -79.056", 
        "Univ of Pennsylvania / Infectious Diseases Division": "39.952 -75.164", 
        "Univ of Texas Southwestern Med Ctr of Dallas": "32.803 -96.77"
    }
}